These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21209351)
41. Behavioral phenotype of neurofibromatosis, type 1. Kayl AE; Moore BD Ment Retard Dev Disabil Res Rev; 2000; 6(2):117-24. PubMed ID: 10899804 [TBL] [Abstract][Full Text] [Related]
43. Detection of a neurofibromatosis type I (NF1) homologous sequence by PCR: implications for the diagnosis and screening of genetic diseases. Gasparini P; Grifa A; Origone P; Coviello D; Antonacci R; Rocchi M Mol Cell Probes; 1993 Oct; 7(5):415-8. PubMed ID: 8264676 [TBL] [Abstract][Full Text] [Related]
44. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1. Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929 [TBL] [Abstract][Full Text] [Related]
45. [Neurofibromatosis type 2 (NF2). Study of 7 patients]. Pascual-Castroviejo I; Pascual-Pascual SI; ViaƱo J Neurologia; 2009 Sep; 24(7):457-61. PubMed ID: 19921555 [TBL] [Abstract][Full Text] [Related]
46. The elephant man. J Audiov Media Med; 1991 Apr; 14(2):59-61. PubMed ID: 1795079 [No Abstract] [Full Text] [Related]
47. The improbable "Elephant Man". Spiring P Biologist (London); 2001 Jun; 48(3):104. PubMed ID: 11399837 [No Abstract] [Full Text] [Related]
48. Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Biesecker LG; Happle R; Mulliken JB; Weksberg R; Graham JM; Viljoen DL; Cohen MM Am J Med Genet; 1999 Jun; 84(5):389-95. PubMed ID: 10360391 [TBL] [Abstract][Full Text] [Related]
50. [Symptomatic tumors in neurofibromatosis type 1: a diagnostic challenge]. Taal W; van Dijk SA; Noordhoek C; Broen MPG; Gijtenbeek JMMA; Oostenbrink R Ned Tijdschr Geneeskd; 2023 Nov; 167():. PubMed ID: 37994710 [TBL] [Abstract][Full Text] [Related]
51. [Neurofibromatosis 1--so easy to diagnose, but so difficult?]. Ruud E Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2484. PubMed ID: 12448124 [No Abstract] [Full Text] [Related]
52. Neurofibromatosis presenting as a severe systemic vasculopathy. Lehrnbecher T; Gassel AM; Rauh V; Kirchner T; Huppertz HI Eur J Pediatr; 1994 Feb; 153(2):107-9. PubMed ID: 8157015 [TBL] [Abstract][Full Text] [Related]
53. NEUROFIBROMATOSIS TYPE I AND ITS DIAGNOSTIC CRITERIA: A CLINICAL OBSERVATION. Purdenko TI; Delva MY; Ostrovskaya LI; Tarianyk KA; Sylenko HY; Pushko OO; Purdenko SV Wiad Lek; 2022; 75(5 pt 2):1408-1414. PubMed ID: 35758466 [TBL] [Abstract][Full Text] [Related]
54. The Elephant Man. Part I. Seward GR Br Dent J; 1990 Sep; 169(6):173-5. PubMed ID: 2119664 [TBL] [Abstract][Full Text] [Related]
55. Segmental neurofibromatosis type 1: a frequently underestimated disease. Dragoni F; Bassi A; Conti R; Moretti S; Campolmi P G Ital Dermatol Venereol; 2013 Dec; 148(6):706-7. PubMed ID: 24442057 [No Abstract] [Full Text] [Related]
56. Resident rounds. Part III. A case of Proteus syndrome. Pickert A; Price H J Drugs Dermatol; 2013 May; 12(5):586-7. PubMed ID: 23652959 [No Abstract] [Full Text] [Related]
57. Anemic nevus is a new diagnostic criterion for neurofibromatosis type 1. Tadini G; Brena M G Ital Dermatol Venereol; 2017 Oct; 152(5):548-549. PubMed ID: 28906098 [No Abstract] [Full Text] [Related]
58. Images in clinical medicine. Neurofibromatosis. Ibrahim A; Asuku ME N Engl J Med; 2011 Nov; 365(21):2020. PubMed ID: 22111720 [No Abstract] [Full Text] [Related]